These results demonstrate the specificity of targeting of CEA- and FAP-targeted IgG-IL2v and show that the heterotypic spheroid model is suitable for the evaluation of tumor- and fibroblast-targeted immunotherapies. Here, CEACAM5 is linked to neoplasm.